Background: Among older, overweight, and obese adults with either cardiovascular disease or the metabolic syndrome, reduced mobility and loss of leg strength are important risk factors for morbidity, disability, and mortality. It is unclear whether community-based approaches to weight loss may be an effective solution to this public health challenge. Methods: An 18-month three-site, randomized controlled trial conducted by YMCA staff, with blinded assessors, enrolled 249 older, overweight, and obese adults with either cardiovascular disease or metabolic syndrome with randomization to three interventions: weight loss alone (WL), weight loss + aerobic training (WL + AT), and weight loss + resistance training (WT + RT). The dual primary outcomes were 400-m walk time in seconds and knee extensor strength in Newton meters. Results: All groups lost weight from baseline: average baseline adjusted change of −6.1% (95% confidence interval [CI]: −7.5 to −4.7) for WL only, −8.6% (95% CI: −10.0 to −7.2) for WL + AT, and −9.7% (95% CI: −11.1 to −8.4) for WL + RT. Combined, the two physical activity + WL training groups had greater improvement in walk time than WL alone (mean difference 16.9 seconds [95% CI: 9.7 to 24.0], p < .0001). Baseline adjusted change in knee extensor strength was no greater with WL + RT than WL + AT (mean difference −3.6 Nm [95% CI: −7.5 to 0.3], p = .07). Conclusions: At risk, older, overweight and obese adults can achieve clinically significant reductions in body weight with community-based weight loss programs. The change in percent weight loss and improvements in mobility are significantly enhanced when either RT or AT is combined with dietary WL.
More than 80 million Americans have some form of cardiovascular disease (CVD) (1) and close to 50% of persons aged 60 and older have the metabolic syndrome (MetS) (2) . Both CVD (3) and MetS (4) are important risk factors for reduced mobility, and the loss of lower extremity strength is a consequence of reduced mobility and aging (5, 6) . The growing population of older adults in the United States (7) coupled with a 40% prevalence of obesity among adults aged 65-74 (8) underscores the urgency to develop community-based approaches to address both the management of weight and the preservation of mobility as people age.
Building on our success with weight loss delivered by experts in obesity treatment (9) , the current study takes the important step of having the interventions delivered exclusively by community partners with our staff as "trainers and advisers." As emphasized in the recent National Institutes of Health (NIH) stage model for intervention research, this approach is critical to identifying interventions that can be effectively disseminated (10) . Additionally, this is the first randomized controlled trial to compare diet-induced weight loss alone (WL) to either WL with aerobic training (AT) or WL with resistance training (RT) on mobility and lower extremity strength among older, overweight, and obese adults with either CVD or MetS. The WL only versus WL + physical activity contrast is important because many commercial programs rely exclusively on modifying diet.
The dual primary outcomes were 400-m walk time and knee extensor strength. The first hypothesis was that physical activity in combination with WL-the average effect of WL + AT and WL + RT-would yield more favorable changes in the 400-m walk than WL alone. The second hypothesis was that WL + RT would yield greater change in knee extensor strength than WL + AT.
Methods

Participant Enrollment, Eligibility, and Recruitment
The design was a multisite, single-blinded, randomized controlled trial involving three YMCAs in Forsyth County, NC. Enrollment occurred between September 2012 and February 2014 with the last follow-up visit in September 2015. Details of the methods have been published (11) . Briefly, the eligibility criteria consisted of men and women aged 60-79 years who engaged in <60 min/wk of moderately intense physical activity, had a body mass index ≥ 28 and < 42, self-reported limitations with mobility, and had documented evidence of CVD or an ATP III diagnosis of MetS (12) . Individuals were excluded if they had severe heart disease, severe systematic disease, had a myocardial infarction or cardiovascular procedure in the past 3 months, a blood glucose ≥ 140 mg/dL, diagnosis of Type I diabetes or insulin-dependent Type II diabetes, or a severe psychiatric condition. Targeted mass mailings to the community were the primary recruitment strategy. The study protocol was approved by the institutional review board at Wake Forest School of Medicine, and the trial was monitored by an independent data and safety monitoring board and was registered at ClinicalsTrials.gov (NCT01547182).
Randomization and Follow-up
Eligible participants were recruited in eight waves of ~30 and randomized individually to one of the three treatment arms at the end of baseline testing using a stratified (by wave) block randomization scheme. Follow-up visits were scheduled at 6 and 18 months.
Study Assessments
The dual primary outcomes were assessed via a validated 400-m walk test (13) that requires walking 10 laps as quickly as possible on a 20-m course between two cones with the time for completion recorded in seconds and an isokinetic dynamometer to assess knee extensor strength as peak torque in Newton meters (11) . For strength testing, two blocks of four maximal efforts were conducted with a rest period of 90 seconds between each block; the average of the four trials in the second block was used for analysis.
Accelerometry was used to assess change in moderate levels of physical activity (14) and has been used previously with older adults (9, 15) . Intensity was scaled from 1 to 9 (low to high); these units are highly correlated with measured, peak oxygen uptake (16) . Intensity levels 4+ contributed to moderate to vigorous physical activity (MVPA). Data were collected over a period of seven continuous days at baseline and all follow-up visits. For data to be valid, participants had to provide at least 4 days of data in which the accelerometer was worn for at least 10 hours each day. RT was captured by self-report because accelerometry cannot capture this type of activity. Height was assessed without shoes to the nearest 0.25 cm using a stadiometer and body mass measured to the nearest 0.05 kg using a calibrated and certified digital scale.
Study Interventions
Weight loss
The three study arms received the same WL intervention in three 6-month phases: intensive (months 1-6), transition (months 7-12), and maintenance (months [13] [14] [15] [16] [17] [18] . During the intensive phase, participants had three group and one individual session each month. Group sessions tapered off to two and then one per month for the subsequent phases with individual sessions scheduled as needed. All sessions lasted 60 minutes. The approach to weight loss involved state-of-the-art methods (9, 17) with the details having been published (11) . The goal was to elicit a 0.3 kg/wk weight loss in the intensive phase with a total weight loss of 7%-10% of body mass. The nutritional composition of the diet was 20%-25% proteins, 25%-30% fats, and 45%-55% carbohydrates. For the three study arms, no specific physical activity goals were provided except for the AT and RT programs described below.
Aerobic training
The primary mode of AT was walking on an indoor cushioned track at the YMCA 4 d/wk, although participants were encouraged to walk at home as well. All sessions were supervised by YMCA staff with the FitLinxx database used to document attendance. Walking behavior was shaped toward a goal of 45 min/session with a walking intensity of 12-14 on the Borg Rating of Perceived Exertion (RPE) Scale (18) .
Resistance training
The RT intervention also involved training 4 d/wk to ensure the time devoted to RT and AT was comparable. An RPE of 15-18 was used as a target intensity for each RT exercise with the training sessions shaped to 45 minutes. Cybex equipment was used with a FitLinxx interface to monitor adherence. Participants completed three sets of 10-12 repetitions on eight machines with initial resistance determined from 1 repetition maximum testing (goal of 75% of 1 repetition maximum). When a participant completed 12 repetitions in the third set for two consecutive days, the resistance was increased to ensure progressive overload. To assist with recovery time, participants rotated exercises on a 2-day schedule: Day 1 included a leg press, hip adduction, hip abduction, calf extension, seated-row, pectoral fly, shoulder press, and rotary torso; Day 2 included leg extension, leg curl, lateral pull down, seated chest press, lateral raise, arm curl, triceps extension, and abdominal crunch.
YMCA Staff Training and Monitoring
Initially, YMCA staff received 12 hours of instruction and practice sessions over a 6-day period delivered in six 1-to 2.5-hour sessions. All YMCA staff completed and maintained the basic Collaborative IRB Training Initiative (CITI) program certification and were certified in cardiopulmonary resuscitation. Following the YMCA staff training, CLIP-II staff assessed treatment fidelity of the WL group sessions by shadowing the YMCA staff during the first 8 weeks to monitor content delivery. The YMCA staff met weekly for 1 hour with the behavioral specialist and the RD for the first 6 months of the study. This time was spent reviewing participants' performance and problem-solving potential or known barriers toward WL and/or increased physical activity. We also evaluated YMCA group leader skills as a means to (a) provide feedback to YMCA intervention staff; (b) provide ongoing training and development; and (c) ensure reliability and consistency in session presentation across all waves of the study. During the first 6 months, YMCA group leaders received three evaluations related to treatment fidelity; thereafter, a minimum of two evaluations occurred during the second 6 months of the study and at least one during the final 6 months. Complete details on monitoring treatment fidelity and staff evaluations are described in a method paper (11) .
Participant Safety
The study had a number of features dealing with participant safety especially because the interventions were delivered in a communitybased setting. Specific procedures are described in detail in a method paper (11) . Briefly, information about CLIP-II testing and intervention procedures was provided to participants' primary care physicians, who had to authorize participation in the study. Our inclusion/ exclusion criteria were also quite stringent, but consistent with the majority of studies of clinical populations. All testing was conducted by trained assessment staff, and warm-up and safety procedures were built into the testing protocols. The exercise intervention was delivered by trained YMCA staff who had experience with exercise prescription in older adults. Participant safety was a major focus of the 12 hours of preliminary training for YMCA staff surrounding the delivery of all three interventions. The YMCA staff were available during exercise sessions to supervise and coach participants during the walking and resistance training sessions. At the beginning of each session, YMCA staff routinely asked participants about changes in their health. The AT and RT protocols were individualized and tailored to the physical capacity of each participant and included warm-up and cool-down procedures.
Statistical Methods
The dual primary comparisons were between WL + physical activity (the average effect of WL + AT and WL + RT) and WL alone (as a one degree-of-freedom contrast) for the 400-m walk test (seconds) and between WL + RT and WL + AT on knee extensor muscle strength in Newton meter at the average of 6 and 18 months. We used two-sided tests at α = .025 to maintain an experiment-wise error rate of 0.05 using the intention to treat principle. Treatment effects were tested using repeated measures analysis of covariance with an unstructured covariance matrix. Covariates used included the baseline value of the end point being analyzed, time (6 or 18 months), and sex as fixed effects and YMCA site and wave within each site as random effects. We used multiple imputation as a sensitivity analysis for the two primary outcome analyses. In a second and separate sensitivity analysis, we examined the strength data normalized by body mass.
Power calculations for the 400-m walk were based on a treatment effect of 20 seconds (19) , and muscle strength was powered for a 20% effect (16 Nm) (20) . Assumed within-group standard deviations were 36.0 seconds and 26.3 Nm (both are estimates of residual error after baseline adjustment). To account for the group delivery (estimated intraclass correlation [ICC] of 0.02 for 400-m walk was also used for strength) and groups of size 7 per wave, we inflated the sample size by 1 + ICC (n − 1) = 1.12 (21) . With 83 participants in each treatment, we had 91.0% power for 400-m walk time and 87.5% power for knee extensor strength using two-sided tests at 0.025. Table 1 provides the baseline descriptive characteristics for participants both for the entire sample and by treatment group. Overall, the average age (SD) was 66.8 (4.7) years with 71.1% women and 32.1% African American. Level of education was diverse with 44.2% having a high school education or less; 84.3% of the sample had MetS with 26.1% having CVD. In addition, there was substantial burden from comorbidities with an average body mass index of 33.8 kg/m 2 (3.6), 74.2% with hypertension and 60.2% having arthritis of the hip or knee. Overall, the three randomized groups were similar on these characteristics. 
Results
Participant Characteristics
Retention and Response to Treatment
As illustrated within the CONSORT Diagram (Figure 1 ), 249 total participants that met the inclusion/exclusion criteria were randomized to treatment for a yield of 12% from the initial phone screen. At the 6-month assessment, 90.3% were retained, whereas at 18 months, this value was 77.1%. There was no differential loss to follow-up as a function of treatment group at either time point: p = .07 at 6 months and p = .268 at 18 months. Comparing dropouts (n = 20) to those with at least one follow-up visit (n = 229) revealed that they did not differ by age, sex, race, knee extensor strength, history of CVD, or percentage with MetS. At baseline, dropouts had a higher mean body mass index, 36.7 versus 33.5 kg/m 2 (p < .01), and a slower mean 400-m walk time, 362.0 versus 332.3 (p = .034).
Median (25th, 75th percentiles) attendance to scheduled treatment sessions was 71.1% (40.5, 83.3) for WL only, 83.1% (47.6, 92.9) for WL + AT, and 85.7% (70.7, 92.7) for WL + RT. All three groups lost significant weight from baseline ( Figure 2 ) with average adjusted changes of −6.1% (95% confidence interval [CI]: −7.5 to −4.7) for WL only, −8.6% (95% CI: −10.0 to −7.2) for WL + AT, and −9.7% (95% CI: −11.1 to −8.4) for WL + RT. The WL only group lost less weight than either WL + AT (mean difference 2.5% [95% CI: 1.0 to 4.0], p = .0013) or WL + RT (mean difference 3.7% [95% CI: 2.2 to 5.2], p < .0001). Also, both the WL + AT and WL + RT sustained weight loss at 18 months, whereas the WL only group regained about 1% of the weight they had lost at 6 months.
As expected, the average adjusted increase in MVPA at followup, as assessed by accelerometry, was 197.7 min/wk in WL + AT, whereas it was negligible in WL only and WL + RT, −13.6 min/wk and 15.8 min/wk, respectively (p < .0001 when comparing WL + AT vs either WL only or WL + RT). Using self-report, on average across follow-up assessments, participants in WL + RT reported engaging in 173.0 min/wk of RT, whereas the means for WL only and WL + AT were 4.2 and 3.4 min/wk (p < .0001 when comparing WL + RT vs either WL only or WL + AT).
Primary Outcomes
Data for the dual primary outcomes, 400-m walk time and knee extensor strength, can be found in Figures 3 and 4 (as well as Supplementary Table 2 ). There was strong support for the first primary hypothesis related to mobility; that is, the combined physical activity groups (WL + AT and WL + RT) resulted in greater improvement in 400-m walk time than WL only ( Figure 3 ; mean difference 16.9 seconds [95% CI: 9.7 to 24.0], p < .0001). Furthermore, follow-up post hoc analyses on the individual group comparisons revealed that 400-m walk time for the WL group was slower than either WL + AT or WL + RT at both the 6-and 18-month follow-up assessments (all p values < .03); there was no difference between WL + AT and WL + RT at either 6 or 18 months (p = .21 at 6 months and 0.27 at 18 months).
Inspection of the data in Figure 4A , revealed that the second primary hypothesis related to knee extensor strength was not supported; that is, there was no difference between WL + RT and WL + AT (mean difference −3.6 Nm [95% CI: −7.5 to 0.3], p = .07). As a sensitivity analysis, we examined the strength data normalized by body mass (22) (Figure 4B ) because, as shown in Figure 2 , there were group differences in weight loss at the follow-up visits. However, in the context of WL for older adults, RT did not result in greater improvement in normalized strength (Nm/kg of body mass) than AT. 
Safety
There were a total of seven serious adverse events reported during the study; no single participant had more than one event. Of the seven events, four were possibly related to the study interventions as determined by the study physician and by the data and safety monitoring board; none were definitively linked to treatment. The three events unrelated to the study included death from a complication due to pulmonary edema with hospitalization; hip fracture that occurred when a participant fell due to uneven pavement; and severe pain from an existing lumbar stenosis. Those four events possibly related to the interventions included a critically low fasting glucose of 11 mg/dL that was detected following a testing visit; surgical repair of torn meniscus in the knee; diagnosis of bulging disc in conjunction with spinal stenosis; and intensification of shoulder pain during the course of the intervention. There was no statistically significant difference between treatment groups (p = .42). The patient who was found to have a fasting glucose of 11 mg/dL following a testing visit was asymptomatic the morning of the testing visit. The patient had no history of diabetes or hypoglycemia, completed all testing including a 400-m walk test without incident, and was asymptomatic between the end of the testing visit and the contact that was made with the patient once the blood values were made available to our staff that evening. The patient followed up with her personal physician, and no further complications were observed.
Discussion
To our knowledge, this is the first study to demonstrate that WL interventions combined with either AT or RT are more effective in improving both mobility and knee extensor strength than WL only. These are clinically important findings because Medicare now provides reimbursement for weight loss, with no specific guidelines or benchmarks for physical activity behavior. The improvement in 400-m walk time of both exercise groups is highly relevant to primary care given the important role of mobility in sustaining independence (23, 24) and the increased risk that loss of mobility confers for both institutionalization and death (13, 25) . Some may find the observation of no difference in 400-m walk time between the WL + AT and WL + RT groups surprising considering the specificity of training in the walking program to the 400-m walk outcome. However, we and others have observed improved walking endurance performance on the 400-m walk task following WL + RT, suggesting that muscle strength plays an important role in endurance walking tasks in older adults particularly those who are overweight or obese (26, 27) . Also, it is worth noting that when participants walked at the YMCA they did so overground rather than using treadmills. The reason is that we have found that overground walking enhances walking performance and results in greater enjoyment with training than treadmill walking (28) .
In contrast to our hypothesis, knee extensor strength was no greater in WL + RT than WL + AT; however, as compared to WL only, the magnitude of change in knee extensor strength observed in either RT or AT with WL was comparable to results from wellcontrolled laboratory studies (5, 29) . Muscular strength is strongly correlated with physical function, yet, inversely and independently related to mortality (5, 30) . Whereas the difference in knee extensor strength between WL and WL with either AT or RT was unexpected, these results do suggest that walking not only improves aerobic fitness, via faster 400-m walk time, but also improves knee extensor strength at a level comparable to RT. However, it is possible that the gain in concentric knee extensor strength in the WL + RT group was blunted (and thus similar to the WL + AT group) as a result of inadequate protein intake and subsequent loss of lean tissue during WL. Whereas in CLIP-II, we set the study goal at a minimum of 0.8 g/kg body weight/d of protein intake with the aim to counsel to a goal of 1.0 g/kg, a recent statement has advised a higher protein intake (≥1.2 g/kg body weight/d) for older adults who are exercising (31) . Currently, there is some equipoise on this issue with limited data on change in muscle strength in the context of WL combined with RT (32, 33) .
Being overweight or obese and accompanying adverse health states such as metabolic dysfunction are highly prevalent among older adults (2,34) with excessive weight being uniquely problematic for this segment of the population given the negative impact it has on physical function (35) . Although a process measure, particularly striking was the magnitude of weight loss in both WL + AT and WL + RT-close to 9 kg in both conditions-a finding that attests to the clinical and translational significance of our findings as reinforced by the NIH stage model (10) . Parenthetically, a recent meta-analysis of pragmatic trials involving weight loss in obese patients at risk for Type II diabetes reported an average effect of −2.3 kg (95% CI: −2.9 to −1.7) (36) .
Additionally, participants in either WL + RT or WL + AT did not regain any weight from 6 months until study close out at the 18 months. Previous weight loss trials indicate that, on average, 30%-50% of lost weight during the intensive phase of treatment is regained by 1 year (37, 38) . Of note, from 6 to 18 months, participants in the WL only group were on an anticipated trajectory of weight regain. Thus, the pattern in our data reaffirms the position from observational data that physical activity is an important factor in mitigating weight regain after WL, another study finding that enhances its clinical significance (39) . Further, we showed that knee extensor strength was preserved equally in both AT and RT, a finding that should mitigate concerns about the deleterious effects of WL on physical function in overweight and obese older adults (40, 41) .
Strengths and Limitations
The strengths of this study include the use of a randomized controlled trial design with analyses based on the principle of intentto-treat. The sample was relatively heterogeneous on demographic characteristics, and more than 30% of the sample was African American. Care was taken to prevent cross contamination between treatment groups, and the investigation was conducted in a community setting using the infrastructure of the YMCA and their staff to conduct the interventions. This has notable features of sound internal and external validity.
However, the investigation has limitations. First, the study sample included persons both with CVD and MetS and we were not powered to examine potential differences between these two subgroups on the outcomes of interest. Second, strength testing was restricted to knee extensor strength, a decision which no doubt constrained our ability to examine strength differences between the WL + RT and WL + AT treatment conditions. Third, based on data from Kwon and colleagues (19) , some might view the difference in 400-m walk time of 16.9 seconds between WL and WL combined with either RT or AT to have marginal clinical significance. Using data from the Lifestyle Interventions and Independence for Elders Pilot (LIFE-P) Study, they propose that a 20-second change in 400-m walk time represents the lower end of the range for clinical significance. However, it is important to point out that the data analyzed by Kwon and colleagues (19) targeted older adults aged 70 and older who had poor mobility. As observed in our previous work (9) , change in function is affected dramatically by baseline performance such that those who perform worse at baseline experience greater improvement. Thus, a clinically significant change in 400-m walk time for more functionally able older adults has yet to be determined, but will clearly fall below what Kwon and colleagues observed. Fourth, we note that participants assigned to a WL + physical activity group demonstrated greater weight loss than did participants assigned to WL alone. It is possible that weight loss mediates the effect of the physical activity treatments on our outcomes and this will need further exploration.
Conclusion
This is the first community-based WL program to demonstrate that overweight and obese, older adults with either CVD or MetS can achieve significant benefit in physical function by engaging in groupmediated weight loss when combined with either RT or AT. With minimal training and monitoring, staff can deliver these interventions safely, achieve weight loss comparable to state-of-the-art weight management programs, and sustain effects across a period of 18 months.
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